About Skyline Ventures
Investments are directed by Skyline Ventures toward life sciences firms in the United States, with a focus on diagnostics, medical devices, and therapeutics. Portfolio holdings include AcelRx, Advion, Collegium Pharmaceutical, and DiscoveRx. Assets under management are valued at 800 million, and typical investment amounts range from 15 million to 35 million per company. Operations are based in Palo Alto.
- Headquarter Palo Alto, United States
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
- Legal Name Skyline Ventures India Limited
- Date of Incorporation 17 Nov, 1988
- Jurisdiction Shaikpet, Telangana, India
-
Annual Revenue
Not available
-
Net Profit
-$2.91 K (USD)50.12as on Mar 31, 2023
-
EBITDA
-$1.2 K (USD)0as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Skyline Ventures
Detailed funding history for Skyline Ventures
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Skyline Ventures
Investment portfolio details for Skyline Ventures
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Skyline Ventures
Detailed financials for Skyline Ventures
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Skyline Ventures Comparisons
Peer comparison for Skyline Ventures
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Skyline Ventures
Detailed competitors of Skyline Ventures
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Skyline Ventures
Complete news archive for Skyline Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skyline Ventures
Skyline Ventures is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Investments are directed by Skyline Ventures toward life sciences firms in the United States, with a focus on diagnostics, medical devices, and therapeutics. Portfolio holdings include AcelRx, Advion, Collegium Pharmaceutical, and DiscoveRx. Assets under management are valued at 800 million, and typical investment amounts range from 15 million to 35 million per company. Operations are based in Palo Alto.